Xbrane Biopharma

Major Shareholding Notification • Apr 23, 2024

Issuer Xbrane Biopharma AB

Holder

Försäkringsaktiebolaget Avanza Pension

Instrument

Instrument	Aktier
Before the transaction
Shares	Data not given*
Voting rights	Data not given*
Transaction
Reason for major shareholding notification Sell
Date	22/04/2024
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	67,606,909
Directly held voting rights	0
Indirectly held voting rights	67,606,909
Percentage
Directly held shares	4.42024 %
Directly held voting rights	0 %
Indirectly held voting rights	4.42024 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	4.42024 %	67,606,909
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled - Cash settled	0.5752 %	8,797,639
Total	4.99544 %	76,404,548

Group total holdings

Voting rights 76,404,548 Percentage of voting rights 4.99544

Notes (other relevant informations according to law)

Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Det är försäkringskunder som via depåfullmakt har avyttrat de aktuella aktierna.

Published

23/04/2024 13:14

Contact

Name Marie Karlsfeldt

Email marie.karlsfeldt@avanza.se

*Source of information has chosen not to submit the data

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25